LilyLink has been chosen to enhance maternal diabetes management in rural New Jersey through a state-backed programme, employing remote glucose monitoring and multilingual support to bridge urban-rural care gaps.
LilyLink says it has been selected to help expand maternal diabetes care for women in rural New Jersey under a state-backed rural health programme, with the company pitching the effort as a way to narrow gaps between urban and rural maternity services. The company said the initiative will focus on remote glucose monitoring, dietitian support and coordinated oversight from maternal-fetal medicine specialists.
According to the announcement, LilyLink will work with rural providers, health centres and community groups to support eligible patients from home, while also trying to improve access for underinsured women and offer services in several languages. The firm said its system pulls in readings from continuous glucose monitors and connected glucometers, then organises the information for clinicians to review more quickly.
The company has previously described itself as a maternal health technology and clinical services business focused on diabetes in pregnancy. On its website, LilyLink says gestational diabetes is common and is often managed with finger-stick testing and paper logs, and it presents its platform as a way to centralise data and support care teams using connected devices and remote monitoring tools.
LilyLink’s rural push comes as other maternity-care groups have been using similar digital models to extend gestational diabetes support beyond traditional clinics. In a recent partnership announcement with Ouma Health, the company said connected monitoring could help improve access to care for pregnant women who might otherwise struggle to keep up with frequent testing and logging.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
